Amphastar Pharmaceuticals, Inc. (AMPH)

Last Closing Price: 25.71 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amphastar Pharmaceuticals, Inc. (AMPH) had Net Income of $159.52M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$731.97M
Net Income
$159.52M
$358.11M
$373.86M
$526.55M
$205.42M
$-15.65M
$189.76M
$189.76M
$160.09M
$159.52M
$159.52M
$160.09M
$205.42M
$264.42M
48.43M
52.06M
$3.29
$3.06
Balance Sheet Financials
$534.07M
$297.35M
$1.04B
$1.58B
$173.76M
$601.63M
$671.41M
$845.17M
$732.30M
$141.64M
$732.30M
47.62M
Cash Flow Statement Financials
$213.39M
$-124.93M
$-80.95M
$144.53M
$151.84M
$7.31M
$24.37M
--
--
Fundamental Metrics & Ratios
3.07
--
--
0.45
0.82
51.08%
28.06%
28.06%
36.12%
25.93%
21.79%
$172.34M
--
--
--
0.46
2.33
5.30
68.83
21.78%
112.62%
10.11%
11.96%
$15.38
$3.31
$4.10